-
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
(PA-18-916)
National Institute on Drug Abuse
Application Receipt Date(s): Standard AIDS dates , by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
(PA-18-917)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp Clinical Trial Optional)
(PA-18-920)
National Center for Complementary and Integrative Health
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): December 1, 2018, by 5:00 p.m. local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
(PAR-18-918)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)
(PAR-18-919)
National Cancer Institute
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is February 5, 2019.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
(PAS-18-915)
National Institute on Drug Abuse
Application Receipt Date(s): Standard AIDS dates , by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional)
(RFA-AG-19-024)
National Institute on Aging
Application Receipt Date(s): February 4, 2019, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
(RFA-CA-18-029)
National Cancer Institute
Application Receipt Date(s): November 15, 2018 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this FOA.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required)
(RFA-CA-18-030)
National Cancer Institute
Application Receipt Date(s): November 15, 2018 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this FOA.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional).
(RFA-CA-19-001)
National Cancer Institute
Application Receipt Date(s): January 9, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
(RFA-CA-19-016)
National Cancer Institute
Application Receipt Date(s): December 7, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)
(RFA-DK-18-017)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): February 21, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Research Sites (U01 Clinical Trial Not Allowed)
(RFA-DK-18-510)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-DK-18-511)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Discovery Sites (U01 Clinical Trial Not Allowed)
(RFA-DK-18-513)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this funding opportunity announcement.
-
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Data Coordinating Core (DCC) (U24 Clinical Trial Not Allowed)
(RFA-DK-18-514)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 1?4, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Tissue and Technology Core (TATC) (U24 Clinical Trial Not Allowed)
(RFA-DK-18-515)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 14, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applicationsallowed for this funding opportunity announcement are due on this date. No late a?p?p?l?i?c?a?t?i?o?n?s will be accepted for this FundingOpportunity Announcement.
-
Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence (R18)
(RFA-HS-18-002)
Agency for Healthcare Research and Quality
Application Receipt Date(s): January 4, 2019 , by 5:00 PM local time of applicant organization
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (R25)
(RFA-NS-19-007)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Nursing Research
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): February 15, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.